Skip to main content

Hepatitis C clinical trials at UCLA

2 in progress, 0 open to eligible people

Showing trials for
  • INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit

    Sorry, accepting new patients by invitation only

    The purpose of this study is to determine the efficacy of using a mobile health delivery unit ("mobile unit") to deliver "one stop" integrated health services - particularly medication for opioid use disorder (MOUD) and medication for HIV treatment and prevention - to people who inject drugs (PWID) with opioid use disorder (OUD) to improve uptake and use of MOUD, and uptake and use of antiretroviral therapy (ART) or pre-exposure prophylaxis (PrEP).

    Los Angeles, California and other locations

  • Prevention Support for People Leaving Jail

    Sorry, in progress, not accepting new patients

    This study will provide HIV prevention and related support services to men who have sex with men and transgender women who have substance use disorders and are either leaving jail or recently released from jail. The researchers will compare the utilization of HIV prevention and other support services between individuals who receive routine case management provided following enrollment to those who have access to GeoPassport, a global position service (GPS)-based mobile app, incentives, and peer mentor support.

    Los Angeles, California and other locations

Our lead scientists for Hepatitis C research studies include .

Last updated: